The bootstrapping method was used to estimate average BG and corresponding HbA1c.
2
Subgroup analyses were done in diabetic patients according to their Hba1C levels.
3
HbA1c determinations were centralized in a Diabetes Control and Complications Trial-controlled laboratory.
4
The HbA1c is a really important test that we use all the time.
5
Conclusions: This study showed that HbA1c is a good predictor of in-hospital morbidity.
1
Primary outcome: We evaluated mean change in blood glycatedhemoglobin levels.
2
Glycemic control was based on glycatedhemoglobin levels and fasting blood glucose test.
3
Measurements and main results: We used admission glycatedhemoglobin to estimate premorbid baseline blood glucose concentration.
4
Higher total cholesterol, glycatedhemoglobin and insulin resistance parameters are connected with lower central dopamine tone.
5
Glucose-lowering therapies were granted regulatory approval primarily from smaller studies that have demonstrated reductions in glycatedhemoglobin concentration.
1
Blood pressure and hemoglobinA1c did not differ among the four groups.
2
BP and insulin resistance, reflected by hemoglobinA1c, were among cardiovascular risk factors.
3
Lipid profile, hemoglobinA1c and systemic blood pressure were measured in all patients.
4
Blood pressure, blood levels of hemoglobinA1c, and serum lipids were also measured.
5
These so-called hemoglobinA1c levels reflect average blood sugar levels over about three months.
1
Baseline BMI predicted greater fasting glucose and HgbA1c levels at 12 months for both treatments.
Uso de a1c en inglés
1
Some SMBG time points had a stronger association with A1C than others.
2
Higher levels of A1c suggest worse blood sugar control and possibly diabetes.
3
Blood pressure and hemoglobin A1c did not differ among the four groups.
4
They were more likely to document patient height, urinalyses results, and A1C values.
5
High A1C levels mean a high risk of complications from diabetes.
6
BP and insulin resistance, reflected by hemoglobin A1c, were among cardiovascular risk factors.
7
Preprandial glucose values have a larger impact on A1C levels than postprandial values.
8
Meta-regression showed an association between higher baseline A1c and a larger effect size.
9
Conclusions: CHW interventions showed a modest reduction in A1c compared to usual care.
10
It compared levels of A1C -a measure of sugar in the bloodstream.
11
A1C is a commonly used measure of blood sugar over time.
12
Lipid profile, hemoglobin A1c and systemic blood pressure were measured in all patients.
13
Blood pressure, blood levels of hemoglobin A1c, and serum lipids were also measured.
14
These so-called hemoglobin A1c levels reflect average blood sugar levels over about three months.
15
A1C is a commonly used measure of a person's average blood glucose over time.
16
There was a graded association between A1C and carotid IMT.